# FDA Inspection 1220703 - Eagle Pharmaceuticals - October 13, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/eagle-pharmaceuticals/ffa2af3f-b8e6-4def-a73b-8d6ef6cb6196/
Source feed: FDA_Inspections

> FDA Inspection 1220703 for Eagle Pharmaceuticals on October 13, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220703
- Company Name: Eagle Pharmaceuticals
- Inspection Date: 2023-10-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1041877 - 2018-02-08](https://www.globalkeysolutions.net/api/records/fda_inspections/eagle-pharmaceuticals/a5af320c-4768-4ac5-b397-749f16e00314/)
- [FDA Inspection 918408 - 2015-03-18](https://www.globalkeysolutions.net/api/records/fda_inspections/eagle-pharmaceuticals/871f9754-1b15-47e3-acb8-9b6c4d491d8b/)

Company: https://www.globalkeysolutions.net/companies/eagle-pharmaceuticals/11fa0d86-ab82-46db-8655-12c31b00f77d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c